Sandoz Group AG (SDZNY)
Sector: Drug Manufacturers - Specialty & Generic
Industry: Drug Manufacturers - Specialty & Generic
Sandoz Group AG
OTC:SDZNYHealthcare · Drug Manufacturers - Specialty & Generic
-0.71%$100.97
CLOSED · Nov 6Prev close$101.69-0.71%Close$100.97
Mkt Cap$43.7B
Float416.44M
O/S432.76M
VOL19K sh
$ Vol$1.93M
RVOL0.70×
Inst Own-
SI<0.1%
Div Yield1.01%
Dilution
Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | 100.55 | 102.63 | 100.43 | 100.97 | 19,740 |
| Nov 5, 2026 | 101.66 | 103.27 | 101.17 | 101.69 | 73,416 |
| Nov 4, 2026 | 101.34 | 101.38 | 100.38 | 101.21 | 16,801 |
| Nov 3, 2026 | 101.28 | 101.54 | 100.37 | 100.66 | 17,916 |
| Nov 2, 2026 | 100.12 | 101.34 | 100.06 | 101.06 | 37,589 |
| Oct 30, 2026 | 101.43 | 101.62 | 99.28 | 99.44 | 42,961 |
| Oct 29, 2026 | 102.78 | 103.22 | 100.60 | 100.75 | 34,865 |
| Oct 28, 2026 | 95.82 | 97.00 | 95.47 | 96.00 | 20,140 |
| Oct 27, 2026 | 98.73 | 99.92 | 98.70 | 99.36 | 20,702 |
| Oct 26, 2026 | 99.87 | 100.34 | 99.04 | 99.68 | 18,558 |
| Oct 23, 2026 | 96.59 | 98.44 | 96.59 | 97.17 | 24,084 |
| Oct 22, 2026 | 95.95 | 96.38 | 95.15 | 96.37 | 32,413 |
| Oct 21, 2026 | 94.61 | 95.35 | 94.50 | 95.00 | 17,512 |
| Oct 20, 2026 | 93.51 | 94.00 | 93.08 | 93.56 | 19,081 |
| Oct 19, 2026 | 93.39 | 93.70 | 92.02 | 92.02 | 16,065 |
| Oct 16, 2026 | 92.15 | 93.53 | 92.15 | 92.98 | 25,879 |
| Oct 15, 2026 | 89.99 | 91.34 | 89.95 | 91.04 | 28,954 |
| Oct 14, 2026 | 87.34 | 88.30 | 87.30 | 88.20 | 28,451 |
| Oct 13, 2026 | 86.38 | 86.38 | 85.71 | 85.87 | 23,039 |
| Oct 12, 2026 | 84.60 | 85.23 | 84.22 | 84.95 | 25,605 |
Analyst Coverage
Analyst Coverage
ConsensusHold
Price Target
Not availableRatings Distribution
BUY2
HOLD3
SELL0
TOTAL5
About
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide.
The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology.
It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.
Key Metrics
Market Cap$43.70B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--
based on 432.76M shares outstanding
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeOTC
Country
CH
CHIPO Date-
Shares Outstanding432.76M
Authorized Shares
Float416.44M
52-Week Range
Volume
Average Daily Volume27.19K
18.94K today vs 27.19K avg(-30%)
30d Avg
27.19K
60d Avg
28.39K
90d Avg
25.29K
Earnings
Dividend History
TTM Yield
1.01%
Paid annually
Annual (LTM)
$1.02
Latest
$1.0207
Apr 14, 26
5Y Growth
--